Table 3 Serial response to the IP-10-based and IFN-γ-based assays in patients with active TB
From: IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
|  | QFT-IT antigens |  | RD1 selected peptides IFN-γ cut-off 0.57 IU/ml |  | ||
|---|---|---|---|---|---|---|
| Â | Time points | Â | Time points | Â | ||
| Â | T0 | T6 | p value | T0 | T6 | p value |
IP-10 Positive over total (%) | 16/17 (94.1) | 14/17 (82.3) | 0.6 | 16/17 (94.1) | 7/17 (41.1) | 0.002 |
IFN-γ Positive over total (%) | 17/17 (100) | 14/17 (82.3) | 0.2 | 16/17 (94.1) | 7/17 (41.1) | 0.002 |
IP-10 N of reversion over total (%) | - | 3/17 (17.6) | Â | - | 10/17 (58.8) | Â |
IP-10 N of conversion over total (%) | - | 1/17 (5.8) | Â | - | 0/17 (0) | Â |
IFN-γ N of reversion over total (%) | - | 3/17 (17.6) |  | - | 9/17 (52.9) |  |
IFN- γ N of conversion over total (%) | - | 0/17 (0) |  | - | 0/17 (0) |  |